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Objective. Our objective was to validate the Pediatric Index of Mortality (PIM) and PIM2 scores in a large cohort of children from a
developing country.Design. Prospective observational study. Setting. Pediatric intensive care unit of a tertiary care teaching hospital.
Patients. All children aged <18 years admitted between June 2011 and July 2013.Measurements and Main Results. We evaluated the
discriminative ability and calibration asmeasured by the area under the receiver operating characteristic (ROC) curves, theHosmer-
Lemeshow goodness-of-fit (GOF), and standardized mortality ratio (SMR), respectively. Of the 819 children enrolled, 232 (28%)
died. The median (IQR) age of the study subjects was 4 years (0.8, 10). The major reasons for ICU admission as well as mortality
were sepsis/severe sepsis.The area under ROC curves for PIM and PIM2was 0.72 (95%CI: 0.67–0.75) and 0.74 (95%CI: 0.70–0.78),
respectively. The goodness-of-fit test showed a good calibration across deciles of risk for the two scores with 𝑃 values being >0.05.
The SMR (95% CI) was 0.99 (0.85–1.15) and 1 (0.85–1.16) for PIM and PIM2, respectively. The calibration across different age and
diagnostic subgroups was also good. Conclusion. PIM and PIM2 scores had good calibration in our setup.
1. Introduction
Scoring systems are used to evaluate the risk of mortality in
intensive care units and form an essential part of providing
intensive care. They allow for interunit and intraunit com-
parisons with time and also provide useful information for
comparing the severity of illness of patients enrolled into clin-
ical trials [1]. The two commonly used mortality risk scoring
systems in children include the Pediatric Risk of Mortality
(PRISM) and the Pediatric Index of Mortality (PIM) scores
[2, 3].While both of these scores have been shown to perform
well across pediatric intensive care units (PICU), the simplic-
ity of the PIM makes it easier to collect data routinely from
large numbers of sick children [4–7]. A number of studies,
predominantly from developed countries as well as from a
few resource-restricted settings, have validated PIM and its
updated version PIM2 scores.
Almost all studies that evaluated the performance of
PIM/PIM2 in units from low- and middle-income countries
had reported excellent “discrimination” but poor “calibration”
of the scores [6–8]. In contrast, in our earlier study on the per-
formance of PIMandPIM2 scores at two different time points
involving 282 sick children, we found not only acceptable
discrimination but also excellent calibration across the deciles
of risk at both of the time points [9]. We were indeed per-
plexed by this unexpected finding. As opposed to discrim-
ination, which is the ability of a model to distinguish accu-
rately between survivors and nonsurvivors in a given unit,
calibration is an actualmeasure of performance of the scoring
system in that unit compared with that of the unit(s) where
the original score was developed. Consequently, it may be
presumed that the current performance of our unit is quite
similar to that of the index units during the time period in
which the scores were developed. Given the stark differences
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in allocation of resources and possibly in the case mix
between the index units and our unit, this presumption defied
logic. One major factor against this presumption was the
possibility of “Type II” error; it is said that the 𝑃 value of
Hosmer-Lemeshow GOF test is unreliable with sample sizes
of less than 400 [10]. The excellent calibration found in our
study could simply be due to the small sample size rather than
due to “good” performance of our unit. We therefore under-
took this study to evaluate the performance of both PIM and
PIM2 scores in a much larger sample of sick children.
2. Methods
2.1. Design and Setting. We conducted this prospective obser-
vational study in our 18-bedded tertiary care PICU from June
2011 to July 2013. Of the 18 beds in the ICU, 10 are in the
“intensive area” while the remaining 8 are in the “step down
area.” Children aged 1 month to 18 years requiring ICU care
from the wards as well as those referred from other hospitals
are admitted in the ICU. Our unit caters to both medical and
postsurgical patients. Children with traumatic injuries are
not admitted in the ICU. The unit is staffed by two full-time
pediatric intensivists, 4 fellows, and 4 residents. A total of 14
nurses are posted in the ICUwith 4-5 nurses per 8-hour shift.
Thenurse to patient ratio is 1 : 3 in the intensive area and 1 : 5-6
in the step down area.The ICU is well equipped with facilities
for continuousmonitoring,mechanical ventilation, blood gas
analysis, ultrasonography, and X-ray facilities.
2.2. Objectives and Outcome Variables. Our primary objec-
tive was to evaluate the discriminative ability and calibration
of PIM and PIM2 scores. The secondary objective was to
assess the calibration across different age and diagnostic
subgroups.The discriminative ability was assessed by the area
under the receiver operating characteristic (ROC) curve [11]
while calibration was assessed using the Hosmer-Lemeshow
GOF test and SMR [12].
2.3. Subjects and Data Collection. We included the data from
all children admitted to the ICU for more than 1 hour during
the study period. Two investigators (AS and SJ) collected the
data during the study period. Both of the investigators were
trained on the methods of data collection by the principal
investigator (JS) at the beginning of the study. The data
recorded by them over the next 2 weeks was cross-checked by
two investigators (JS and MJS) to ensure correctness; dis-
crepancies, if any, were discussed and resolved. The data col-
lected included all variables of PIM and PIM2, demographic
characteristics, clinical course, and outcomes of the study
population. Further details on methodology are provided in
our previously published article on PIM and PIM2 scores at
different time points [9]. Data for 50 children each were
recorded in duplicate during the first and the second years of
study to ensure accuracy. The interobserver reliability was
found to be excellent (𝜅 score = 0.93).
2.4. Statistical Analysis. Data was entered into Microsoft
Excel 2007 (Microsoft Corp., Redmond, CA) and analyzed
using Stata 11.2 (StataCorp, College Station, TX). Categorical
data are presented as number (%) while continuous variables
are presented as mean (SD), if normally distributed, and
median (interquartile range), if skewed. Statistical analysis
was performed using Student’s 𝑡-test/Wilcoxon rank sum test
and chi-square test for continuous and categorical variables,
respectively. A 𝑃 value of 0.05 was considered significant.
Theperformance of PIMandPIM2 scoreswas assessed by
area under ROC curve for discrimination and Hosmer-
Lemeshow GOF 𝑃 values and SMR for calibration across
deciles of risk, age, and diagnostic subgroups
2.5. Ethics and Informed Consent. The protocol was cleared
by institutional Ethics Committee. Informed consent was
taken from one of the parents of enrolled children.
3. Results
There were a total of 855 admissions during the study period,
of which 23 children died within 1 hour and were excluded.
Parents of 13 children refused to give consent. The final
dataset was comprised of 819 children of whom 232 died
(28%) (Figure 1). Data collection of all variables of PIM and
PIM2 was possible throughout the study period.
The demographic features, clinical course, and laboratory
features of the survivors and the nonsurvivors are provided
in Table 1. The median age of the enrolled children was 4
years with the majority being boys (57%). About 28% of the
children were less than 1 year of age, 25% were between 1 year
and 4 years of age, 22%were between 5 and 10 years of age, and
25% were >10 years of age. About one-fifth (𝑛 = 164, 20%) of
the children were severely malnourished.
Themajor reasons for ICU admission as well as mortality
were sepsis/severe sepsis and cardiac and neurological
illnesses. Most of the patients (573, 70%) were admitted
directly from the emergency department while the remaining
patients were either elective (post-op) or referred from other
pediatric wards. The common underlying illnesses in the
study population were congenital/structural heart diseases,
neurometabolic disorders, and tubercular meningitis
(Table 1).
The major cause of death was refractory shock (38%),
refractory hypoxemia (25%), raised intracranial pressure and
cerebral herniation (15%), and refractory congestive heart
failure (22%). The median (IQR) time to death was 5 (3.5, 6)
hours.
3.1. Primary Outcomes. Figures 2 and 3 show the area under
the ROC curves of PIM and PIM2 scores. The area under the
curves (AUC) of PIM and PIM2 scores was 0.72 (95% CI:
0.67–0.75) (Figure 2) and 0.74 (95%CI: 0.70–0.78) (Figure 3),
respectively. Both scores showed good calibration across
deciles of risk as measured by the GOF test with Hosmer-
Lemeshow 𝑃 > 0.05 (Table 2). Calibration as measured by
SMR was also good for the two scores. The number of deaths
predicted by PIM was 232.1 (SMR 1; 95% CI: 0.88–1.13)
and by PIM2 was 232 (SMR 0.99; 95% CI: 0.87–1.12). A closer
look across each decile of risk showed that both PIM and
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Children admitted to the ICU (n = 855)
Excluded (n = 36)
(1) Died within 1hour (n = 23)
(2) Parents refused to give 
Enrolled (n = 819)
consent (n = 13)
ICU: Intensive care unit
Survived (n = 587; 72%) Died (n = 232; 28%)
Figure 1: Study flow.
Table 1: Baseline characteristics of study patients.




(𝑛 = 232) 𝑃 value
Median age in years 4 (0.8, 10) 3.5 (1, 10) 3 (0.7, 10) 0.47
Boys 467 (57) 352 (60) 95 (57) 0.57
Elective admission 30 (3.7) 22 (3.7) 8 (3.4) 0.93
Severe PEM 164 (20) 111 (19) 49 (21) 0.23
Diagnostic subgroups (admission) <0.001
Sepsis/severe sepsis 377 (46) 282 (48) 95 (41) 0.02
Cardiogenic shock/CHF/arrhythmia 98 (18) 36 (6) 62 (26) 0.8
Status epilepticus/raised ICP (noninfective) 82 (10) 31 (5) 51 (22) 0.08
Respiratory (noninfective) 49 (6) 47 (8) 2 (0.8) 0.004
Postoperative patients 28 (3.4) 27 (5) 1 (0.6) 0.67
Poisoning 98 (12) 97 (17) 1 (0.6) <0.001
Liver failure 25 (3) 13 (2) 12 (5) 0.27
Other conditions (aplastic anemia/DKA/hypertension/uremic
encephalopathy) 62 (7.5) 54 (9) 8 (3) 0.06
High risk diagnosis (PIM) 74 (9) 41 (7) 33 (14) 0.016
High risk diagnosis (PIM2) 73 (8.9) 42 (7.1) 31 (13) 0.01
Low risk diagnosis (PIM2) 44 (5.4) 40 (6.8) 4 (1.7) 0.01
Any underlying chronic illness 311 (38) 200 (34) 111 (48) <0.001
Chronic kidney disease 29 (3.6) 24 (4) 5 (2) 0.46
Congenital/structural heart disease 123 (15) 65 (11) 58 (25) 0.21
Chronic liver disease 4 (0.5) 1 (0.1) 3 (1.3) 0.21
Nephrotic syndrome 49 (6) 47 (8) 2 (0.8) 0.07
Neurometabolic disorder/birth asphyxia/developmental delay 41 (5) 23 (4) 18 (7.7) 0.07
Tubercular meningitis 25 (3) 12 (2) 13 (5.6) 0.01
Malignancies/aplastic anemia/immunodeficiencies 40 (5) 28 (5) 18 (8) 0.1
Hospital course
Need for MV during 1st hour 180 (22) 78 (13) 102 (44) <0.0001
Need for blood products 368 (45) 200 (34) 168 (72) <0.0001
Median duration of inotropes (hrs.) 48 (30, 96) 72 (48, 96) 48 (24, 72) 0.005
Median duration of ventilation (hrs.) 48 (24, 76) 52 (39, 96) 48 ( 23, 72) 0.16
Median duration of ICU stay (days) 5 (2, 7) 4 (2, 6) 5 (3, 7) 0.02
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Table 2: Calibration across deciles of risk and standardized mortality ratios for the two scores.
Model Probability of deathacross 10 risk groups
Deaths across deciles of risk Hosmer-Lemeshow goodness-of-fit test Standardized Mortality
Ratio (95% CI)Observed Expected Chi-square 𝑃 value
PIM 11.1 0.20 1 (0.88–1.13)
Group 1 0.14 15 9.4
Group 2 0.16 14 12
Group 3 0.17 6 13.4
Group 4 0.19 13 14.8
Group 5 0.21 18 16.4
Group 6 0.24 16 18.6
Group 7 0.30 23 22.2
Group 8 0.40 33 29.2
Group 9 0.56 36 38.3
Group 10 0.96 58 57.8
PIM 2 12 0.16 0.99 (0.87–1.12)
Group 1 0.13 14 8.3
Group 2 0.15 10 11.7
Group 3 0.17 7 12.8
Group 4 0.18 13 14.3
Group 5 0.21 15 15.9
Group 6 0.25 17 18.8
Group 7 0.32 27 22.9
Group 8 0.40 27 29.4
Group 9 0.58 45 38.4
Group 10 0.94 57 59.4











0.00 0.25 0.50 0.75 1.00
Area under ROC curve = 0.7195
1 − specificity
Figure 2: Area under the ROC curve for PIM score. PIM: Pediatric
Index of Mortality; ROC: receiver operating characteristic.
PIM2 scores underpredicted deaths in groups with probabil-
ity<13%. In addition, PIMunderpredicted deaths between 30
and 40%, while PIM2 underpredicted deaths in groups with
probability between 40 and 57%. Overprediction was evident
in the risk groups of 15–17% for both PIM and PIM2 scores
(Table 2).











0.00 0.25 0.50 0.75 1.00
1 − specificity
Figure 3: Area under the ROC curve for PIM2 score. PIM2:
Pediatric Index ofMortality; ROC: receiver operating characteristic.
3.2. Secondary Outcomes. Calibration across different age
and diagnostic subgroups was also good with GOF 𝑃 values
being >0.05 across most of the subgroups for both PIM and
PIM2 scores (Table 3). Individually, PIM2 score had good cal-
ibration across all age categories in comparison to PIM score
which had poor calibration among children in the 2–5-year
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Table 3: Calibration of the scores across age and diagnostic subgroups.











<1 year 229 (28) 0.64 9.8 (0.27) 0.67 10 (0.2)
1–4 years 205 (25) 0.80 11 (0.06) 0.79 8.3 (0.4)
5–10 years 180 (22) 0.74 10.45 (0.23) 0.79 3.9 (0.8)
≥10 year 205 (25) 0.75 6.9 (0.5) 0.75 7.2 (0.5)
Diagnoses
Sepsis 377 (46) 0.73 6.3 (0.6) 0.74 7.7 (0.45)
Cardiac 98 (18) 0.62 0.38 (8.5) 0.70 4.4 (0.8)
Neurological 82 (10) 0.73 0.19 (11) 0.75 5.6 (0.7)
Respiratory 49 (6) — — 0.97 0.45 (1)
Postoperative 28 (3.4) — — 0.68 13 (0.05)
Poisoning 98 (12) — — — —
Liver failure 25 (3) 0.70 6.9 (0.5) 0.85 10 (0.22)
Other conditions 62 (7.5) 0.60 9 (0.33) 0.5 8.2 (0.4)
age group. Between the diagnostic subgroups, calibration
was poor only in postoperative patients for the two scores.
Discrimination was best for respiratory illnesses, poisoning,
liver failure, and tubercular meningitis for the two scores
(Table 3).
4. Discussion
The results of the present study confirm our earlier findings
of excellent calibration but acceptable discriminatory per-
formance of both PIM and PIM2 scores in our setup. The
numbers of predicted and observed deaths were almost equal
for both scores across deciles of risk, age, and diagnostic sub-
groups. The results of our previous study were therefore not
merely due to chance. As previously mentioned, calibration
is an important measure of validation of a scoring system in
a unit in which it was not developed. The measure of
calibration—SMR—is basically a comparison of the number
of deaths predicted by the scoring system with the number of
observed deaths. According to the investigators of the origi-
nal PIM and PIM2 scores, the SMR that is significantly differ-
ent from 1 in a given unit means that the standard of care in
that unit is worse (or better, depending on the direction) than
the units that derived the score [10]. It is but natural to expect
that the observed deaths in a given unit would be similar to
the number of expected deaths so that the SMRequals 1.How-
ever, this is often not true, and, depending on the case mix
and disease patterns, the SMRmight vary andmay be signifi-
cantly different from 1 (i.e., 95%CI of SMRwould not include
1); in these cases, the Hosmer-Lemeshow 𝑃 values would be
less than 0.05.
The results of our study are different from most other
studies fromdeveloping countries that reported themodels to
be underpredicting the deaths in their setup, with the SMR
and its 95% CI being more than 1 [6–8]. For example, two
studies from India and Pakistan have reported SMRs as high
as 1.57 to 3.3 and 1.4 to 1.57 for PIM and PIM2 scores, respec-
tively [7, 8]. The study authors have attributed this to the
differences in the patient profile, need to manage large
numbers of severely ill children with limited manpower and
resources, and possible differences in quality of care between
their units and the units where the models where developed.
In contrast, we found the SMR to be equal to 1 not only across
deciles of risk but also across all age and diagnostic sub-
groups. We presume that factors like the threshold for
initiating and discontinuing support, timing of intensive care
admissions, and quality of care as well as the accuracy of data
collectionmight have contributed to the near-perfect SMR in
our unit. It appears that resource limitation may not be a
major deterrent to imparting quality care in the ICU. It may
be more important to review the systems in place and take
steps to improve them in order that the performance of the
models improves in units where the models underpredict
deaths.
Unlike the units inwhich the scoreswere developed [3, 13]
and most other units from developed countries [5, 14–17],
we found only acceptable discrimination of the scores in our
setup. The possible reasons for this difference are the high
mortality rates in our study (28%) as compared to the units
in which the scores were developed or validated (5-6%) [3, 13]
and the difference in disease patterns between these units and
our unit. For example, we had more children with sepsis,
cardiac and neurological illnesses, and raised intracranial
pressure. These factors could not be accounted for by the
variables used to calculate the scores. Moreover, the case mix
and the severity of illness at admission resulted in regression
coefficients that are quite different between the development
set and our study for some of the items of the scores (Table 4).
For example, the coefficient of the item “elective admission” in
PIM score was less than half of the original dataset. This is
possibly due to the fact that almost all admissions in our setup
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Table 4: Logistic regression model of PIM and PIM2 in the study sample.
Coefficient (95% CI) in our study 𝑃 value Coefficient (95% CI) in development set 𝑃 value
Variables: PIM
Pupils fixed to light (yes/no) 2.38 (1.32, 3.44) 0.004 2.35 (1.87, 2.84) <0.00005
Specified diagnosis (yes/no) 0.73 (0.04, 1.42) 0.037 1.82 (1.45, 2.2) <0.00005
Elective admission (yes/no) −0.67 (−1.74, 0.39) 0.21 −1.55 (−1.94, −1.16) <0.00005
Mechanical ventilation (yes/no) 1.72 (1.24, 2.19) <0.001 1.34 (0.95, 1.72) <0.00005
Absolute (SBP-120) mmHg 0.19 (0.006, 0.33) 0.004 0.021 (0.014, 0.027) <0.00005
Absolute base excess (mmol/l) 0.004 (0.03, 0.04) 0.845 0.071 (0.046, 0.095) <0.00005
100× FiO2/PaO2 (mmHg
−1) 0.89 (0.28, 1.49) 0.004 0.41 (0.23, 0.59) <0.00005
Constant −2.48 (−3.01, −1.9) −4.873 (−5.25, −4.49)
Variables: PIM 2
Pupils fixed to light (yes/no) 2.67 (1.51, 3.8) 0.008 3.07 (2.77, 3.38) <0.0005
Elective admission (yes/no) Omitted — −0.92 (−1.17, −0.6) <0.0005
Mechanical ventilation (yes/no) 1.89 (1.41, 2.37) <0.001 1.37 (1.08, 1.65) <0.0005
Absolute (SBP-120) mmHg 0.01 (0.005, 0.03) 0.008 0.01 (0.013, 0.017) <0.0005
Absolute (base excess) mmol/l 0.006 (0.03, 0.04) 0.77 0.10 (0.09, 0.11) <0.0005
100× FiO2/PaO2 (mmHg
−1) 0.97 (0.34, 1.6) 0.002 0.28 (0.20, 0.37) <0.0005
Recovery post procedure (yes/no) 0.98 (−2.1, 0.1) 0.09 −0.93 (−1.2, −0.6) <0.0005
By pass (yes/no) Omitted 0.75 (0.39, 1.10) <0.0005
High risk diagnosis (yes/no) 0.78 (0.10, 1.4) 0.023 1.68 (1.5, 1.8) <0.0005
Low risk diagnosis (yes/no) −0.99 (−2.2, 0.29) 0.13 −1.57 (−2.02, −1.12) <0.0005
Constant −2.55 (−3.1, −1.9) −4.88 (−5.11, −4.6)
SBP: systolic blood pressure; FiO2: fraction of inspired oxygen; PaO2: partial pressure of oxygen; PIM: Pediatric Index of Mortality; CI: confidence interval.
are emergency in comparison to the development sets where
almost 50% of the admissions are elective. Similarly the vari-
able “cardiac bypass” was omitted from the PIM2 model as
there were no patients admitted after such procedure in our
unit. When it came to the variables of high risk and low risk
diagnosis there were major differences between the develop-
ment set and our setup with regard to these. For example,
poisoning has a low risk of mortality in our setup and this
could not be accounted for in the PIM2 “low risk diagnosis”
variable as it does not have poisoning among its low risk
diagnoses category. Among the cardiac illnesses, only dilated
cardiomyopathy or myocarditis is included in the “high risk
diagnoses category” of both PIM models. In our unit, only 2
of the 10 children with an admission diagnosis of acute
myocarditis died. Despite these differences, we did not try to
improve on the fit of themodel by changing the coefficients as
this defeats the main purpose of these models which is to
allow for interunit comparisons [3, 10, 13]. A few studies from
the developed countries did report only acceptable discrim-
ination for PIM and PRISM [4, 18]. One of these studies
attributed the poor discrimination to differences in patient
demographics and physiologic response to different diseases
[18].
The dichotomy between discrimination and calibration
that we observed in our study has been previously reported in
only a few studies. A study from Trinidad reported an AUC
for PIM2 of only 0.62while the SMRwas 0.86with the 95%CI
including 1 [19].The authors attributed this to overprediction
of mortality in their study, but it could mean that their
unit performed better than the development sets. Similarly, a
study of 303 patients from the Netherlands reported an AUC
of 0.74 for PIM score and an SMR of 0.88 with the 95% CI
including 1 [4]. It is often said that a perfectly calibratedmodel
may not always be perfectly discriminatory as the area under
the ROC curve would be 0.83 and not 1 in such cases [20].
Strengths and Limitations. The strengths of our study are: (a)
it is the largest study till date from developing countries to
validate the PIM and PIM2 scores, (b) data were collected
accurately, and (c) the scores were calibrated well in our setup
with an adequate sample size, therebymeaning that the scores
could be used in units with resource limitation as such with-
out anymodifications.The only limitation is that it is a single-
unit study. However, this fact is unlikely to affect the gener-
alization of our results as our unit is fairly representative of
most units form developing countries with high incidence of
sepsis, tuberculosis, and meningoencephalitis cases.
5. Conclusion
Contrary to most previously published studies from devel-
oping country settings, PIM and PIM2 scores had good
calibration in our setup.The good calibration was despite the
differences in case mix and resource allocation between the
units where the scores were developed and ours.
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